Search the Newsreel

Datasea Inc (DTSS) Stock News Today

This article from TradingKey provides current stock information for Datasea Inc (DTSS). It details the stock's closing price, market capitalization, and indicates that more news, earnings reports, analyst ratings, and key developments will be available soon.

Ventas Inc (VEN) Q2 2023 Earnings Report - Results, Call & Slides

Ventas Inc. (VEN) reported its Q2 2023 earnings, beating analyst expectations for both EPS and revenue. The company announced an actual EPS of CHF0.21 against a consensus of CHF0.02, and actual revenue of CHF893.96M compared to an expected CHF881.06M, marking an 8.15% year-over-year revenue …

Cintas (CTAS) Just Overtook the 20-Day Moving Average

After reaching an important support level, Cintas (CTAS) could be a good stock pick from a technical perspective. CTAS surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend. The 20-day simple moving average is a well-liked trading tool because it provides …

Assenagon Asset Management S.A. Has $207.09 Million Stock Position in Cintas Corporation $CTAS

Assenagon Asset Management S.A. significantly increased its stake in Cintas Corporation, now holding 1.22 million shares valued at $207.09 million. Cintas continues to impress with strong earnings and revenue growth, beating analyst expectations and increasing its quarterly dividend. The company maintains a "Moderate Buy" …

NVTS Stock Pops As AI Power Pivot Drives Bullish Guidance

Navitas Semiconductor (NVTS) stock surged over 9% following better-than-expected Q3 revenue guidance and a strategic pivot towards high-power GaN and SiC markets driven by AI data centers. The "Navitas 2.0" plan focuses on high-value AI infrastructure, which is projected to exceed one-third of sales …

CTAS|Cintas Corp|Price:203.050|Chg%:+0.900

Cintas Corp (CTAS) has healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Professional & Commercial Services industry. The stock has high institutional ownership and analysts rate it as a "Buy," with expectations for an upward trend in the …

TaskUs (TASK) Stock Jumps On AI Growth And Cash Flow Strength

TaskUs (TASK) stock surged 24% following a strong Q2 2026 earnings report, driven by growth in its AI Services revenue and robust cash flow generation. The company's adjusted EBITDA margin reached 18.7%, and it raised its full-year cash guidance, signaling a successful pivot towards …

Kore Potash reports unchanged CDI and share capital for July

Equitas Small Finance Bank schedules four investor meets in Aug-Sep 2026

Navitas Semiconductor Corporation (NASDAQ:NVTS) Receives Consensus Recommendation of "Hold" from Analysts

Analysts have issued a consensus "Hold" rating for Navitas Semiconductor (NASDAQ:NVTS), with an average 12-month price target of $15.92. The company recently reported quarterly revenue of $10.53 million, beating estimates, while adjusted EPS of ($0.04) met expectations, though revenue was down 27.3% year over …

Navitas Semiconductor disputes Wolfspeed patent complaint

Navitas Semiconductor is disputing patent infringement allegations filed by Wolfspeed in a Delaware District Court. Navitas, which manufactures gallium nitride and silicon carbide power semiconductors, stated it would defend itself against what it characterized as baseless accusations, asserting its technology is a result of …

Alpargatas (ALPA4): 2T com resultados fortes

Why Is NVTS Stock Rising Today?

Navitas Semiconductor (NVTS) stock rose over 20% after the company announced its new 800 V-to-6 V DC-DC power chip is being showcased in Nvidia’s MGX Ecosystem at Computex 2026. This collaboration aims to help data centers consume electricity more efficiently and address the high …

EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus

Editas Medicine (EDIT) reported a narrower-than-expected loss of 15 cents per share in Q2 2026, with revenues significantly surpassing estimates at $11.9 million due to deferred revenues. The company's lead gene-editing candidate, EDIT-401, for heterozygous familial hypercholesterolemia, showed encouraging preclinical data with rapid and …

Editas Medicine, Inc. 2026: Revenue $11.89M, EPS ($0.15) — 10-Q Summary

Editas Medicine, Inc. reported an increase in collaboration and research revenue to $11.89M for the quarter ended 2026, with a reduced net loss of ($18.23M) and improved diluted EPS of ($0.15). Key highlights include the nomination of EDIT-401 as the lead in vivo candidate …

Datasea Inc (DTSS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Datasea Inc (DTSS), including future EPS and revenue growth estimates. It notes that the company's stock is currently trading at $0.785 and lists its market capitalization. The article also presents a peer comparison with other companies in …

Here's How Much a $1000 Investment in Cintas Made 10 Years Ago Would Be Worth Today

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

Navitas Semiconductor (NVTS) Guides Higher And Adds A SiC Partnership, Is The Stock Cheap?

Janus Henderson Group PLC Purchases 8,623 Shares of Cintas Corporation $CTAS

Janus Henderson Group PLC increased its stake in Cintas Corporation (NASDAQ:CTAS) by 20% in the first quarter, acquiring an additional 8,623 shares, bringing their total holdings to 51,716 shares valued at $8.75 million. Cintas has consistently exceeded quarterly expectations, reporting strong revenue growth and …

Pacer Advisors Inc. Lowers Stake in Cintas Corporation $CTAS

Pacer Advisors Inc. significantly reduced its stake in Cintas Corporation (NASDAQ:CTAS) by 34.8% in the first quarter, selling over 21,000 shares. Despite this, Cintas continues to exceed earnings expectations, reporting $1.29 EPS and $2.91 billion in revenue, and has increased its quarterly dividend. The …

Navitas Semiconductor Corporation $NVTS Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp increased its stake in Navitas Semiconductor Corporation (NVTS) by 21.8% in the first quarter, now holding 566,465 shares valued at $4.97 million. Institutional investors collectively own 46.14% of NVTS, while analysts maintain a "Hold" rating with a consensus …

Taseko Mines Q2 2026 Earnings Call Transcript

TaskUs, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TASK) 2026-08-06

Stratasys (SSYS) to Announce Quarterly Earnings on Thursday

[10-Q] TaskUs, Inc. Quarterly Earnings Report

TaskUs (NASDAQ:TASK) Shares Gap Up on Earnings Beat

Tasty Bite Eatables Limited (TASTYBITE.NS) stock price, news, quote and history

Tasman Resources Issues 30 Million Unquoted Options Under Employee Incentive Scheme

Intrepid Potash (IPI) Stock Faces Profit Pressure Despite Better Margins

Intrepid Potash (IPI) stock, trading at a P/E of 28.5x, saw a slight share price slip despite improved gross margins and adjusted EBITDA in Q2 2026. While operational efficiencies and higher realized prices for TRIO and potash supported a bullish outlook, net income from …

Intrepid Potash Inc (IPI) (Q2 2026) Earnings Call Highlights: Strong Margin Growth and Raised ...

Key Points Interested in Intrepid Potash, Inc? Here are five stocks we like better. Profitability improved in Q2: Adjusted EBITDA rose to $17.5 million from $13.8 million, while gross margin increased 35% to $16.6 million, driven by stronger Trio margins and improved potash operations. …

Galantas Gold Wins Key Permits to Restart Chilean Andacollo Mine

Press Release: Editas Medicine Announces Second Quarter 2026 Results and Business Updates

Editas Medicine (NASDAQ: EDIT) announced its second quarter 2026 financial results and provided business updates. The company highlighted recent progress in its CRISPR-based therapeutic programs and discussed its financial position, offering insights into its strategic direction and upcoming milestones for the remainder of the …

TaskUs (NASDAQ:TASK) Releases Earnings Results, Beats Estimates By $0.05 EPS

Editas Medicine (NASDAQ:EDIT) Issues Earnings Results

Editas Medicine (NASDAQ:EDIT) announced its quarterly earnings, reporting an adjusted loss of $0.15 per share, surpassing the consensus estimate of a $0.27 loss, with revenue of $11.89 million, significantly exceeding analyst expectations of $2.85 million. Despite beating revenue and EPS estimates, the company remains …

Earnings call transcript: TaskUs beats Q2 2026 estimates and lifts outlook

Editas Medicine (EDIT) Reports Q2 Loss, Beats Revenue Estimates

Editas Medicine (EDIT) reported a Q2 loss of $0.15 per share, surpassing the Zacks Consensus Estimate of a $0.3 loss and representing a 50% surprise. The company also beat revenue estimates with $11.89 million, significantly higher than the $3.58 million from the previous year. …